On 22 October 2021, Ethiopia launched a polio vaccination campaign with type 2 novel oral polio vaccine (nOPV2) targeting over 17 million under-five children aiming to end the circulation of vaccine-derived poliovirus. The campaign was officially launched by the Ministry of Health and polio partners in Hawassa, Sidama, alongside the commemoration of World Polio Day with the theme, “One Day. One Focus: Ending Polio: Delivering on the promise of a polio-free world”.
Speaking on behalf of WHO and UNICEF, Deputy WHO Representative in Ethiopia Dr Rose-Mary Nonhlanhla Dlamini underscored the need to ensure that every child everywhere in Ethiopia is vaccinated. She called on vaccinators to work with extra diligence, and on parents and caregivers to present their children for vaccinations.
During the event, Ms. Tsinukal Melkamu, a polio survivor shared her story of living with polio and expressed her hope that no other children will face the challenges she faced because of polio. Ms. Tsinukal was also presented with a letter of thanks from the WHO Regional Director for Africa, Dr Matshidiso Moeti, for sharing her life experience at the 71st session of the WHO Regional Committee for Africa in August 2021.
In 2020, the WHO Africa Region was certified wild polio-free but vaccine-derived poliovirus still continues to circulate in under-served communities.
In a bid to ensure all forms of polio are eradicated, the GPEI has introduced the novel OPV type two (nOPV2) vaccine as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2).
With the launch of nOPV2 vaccine, Ethiopia joins five other frontrunner countries, Benin, Congo Republic, Liberia, Nigeria and Sierra Leone that have already introduced the vaccine.
State Minister of Health, Honorable Dr Dereje Duguma urged health workers, partners, religious leaders, parents, caregivers, and other stakeholders to support this campaign. “We each must do our part to ensure that all under-five children are vaccinated,” He further reminded vaccinators and communities to be mindful of COVID-19 prevention measures as nOPV2 vaccines are being administered. WHO and UNICEF supported the government on the groundwork to fulfill the readiness criteria for nOPV2 introduction, and in planning this nationwide campaign including the development of all campaign preparedness and implementation tools and guidelines, providing budget and training on various aspects of the campaign and post-campaign activities and by deploying more than 100 technical experts to regions and zones to support monitoring and supervision during implementation of the campaign.
The Ministry of Health, WHO, UNICEF, and other polio partners reaffirmed their collective commitment to deliver on the promise of a polio-free Ethiopia and polio-free world for current and future generations.
Distributed by APO Group on behalf of WHO Regional Office for Africa.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
